This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991; 78: 3269–3274.
Dearden CE, Matutes E, Cazin B, Tjonnfjord GE, Parreira A, Nomdedeu B et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood 2001; 98: 1721–1726.
Keating MJ, Cazin B, Coutre S, Birhiray R, Kovacsovics T, Langer W et al. Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed. J Clin Oncol 2002; 20: 205–213.
Mercieca J, Matutes E, Dearden C, MacLennan K, Catovsky D . The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. J Clin Oncol 1994; 12: 2588–2593.
O’Brien S, Kurzrock R, Duvic M, Kantarjian H, Stass S, Robertson LE et al. 2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders. Blood 1994; 84: 733–738.
Palomera L, Domingo JM, Agullo JA, Soledad Romero M . Complete remission in T-cell prolymphocytic leukemia with 2-chlorodeoxyadenosine. J Clin Oncol 1995; 13: 1284–1285.
Nishihira H, Kato K, Isoyama K, Takahashi TA, Kai S, Kato S et al. The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis. Br J Haematol 2003; 120: 516–522.
Jaffe ES, Harris NL, Stein H, Vardiman JM . Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.
Collins RH, Pineiro LA, Agura ED, Fay JW . Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 21: 627–628.
Murase K, Matsunaga T, Sato T, Kuribayashi K, Kogawa K, Kawano Y et al. Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement. Int J Clin Oncol 2003; 8: 391–394.
Garderet L, Bittencourt H, Kaliski A, Daniel M, Ribaud P, Socie G et al. Treatment of T-prolymphocytic leukemia with non myeloablative allogeneic stem cell transplantation. Eur J Haematol 2001; 66: 137–139.
Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ . Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257–260.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanimoto, T., Hirano, A., Nagafuji, K. et al. Mismatched unrelated cord blood transplantation in a patient with T-cell prolymphocytic leukemia. Leukemia 19, 679–681 (2005). https://doi.org/10.1038/sj.leu.2403669
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403669